Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs iShares MSCI India ETF (INDA) Price & Performance

Cytokinetics IncTrade
iShares MSCI India ETFTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs iShares MSCI India ETF — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while iShares MSCI India ETF trades at $50.06. The key difference: Cytokinetics Inc is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals.

CYTKINDA
Market Cap
$10.63B
Sector
TechnologyBroad Market / Factor
52-Week High
$87.26$55.29
52-Week Low
$34.31$45.42
Enterprise Value
$10.74B

Returns comparison

Trailing returns across standard periods

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About iShares MSCI India ETF

INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.

Read more on INDA